This guidance has been produced by the Clinical Oncology Society of Australia (COSA) as part of a national Youth Cancer Networks Program project funded by the Australian Government.
The guidance provides evidence-based recommendations and ‘good practice points’ to assist health professionals in effectively and fully discussing with their AYA patients and their families:
- the potential risk of cancer treatments to fertility
- fertility preservation options for AYAs diagnosed with cancer
- potential late effects and the need for assessment and monitoring of reproductive, sexual and endocrine health after cancer treatment ends.
Information about the purpose, target audience and development of this guidance is in the Introduction